Interest Paid, Excluding Capitalized Interest, Operating Activities of Silexion Therapeutics Corp from 30 Jun 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
Silexion Therapeutics Corp quarterly and annual Interest Paid, Excluding Capitalized Interest, Operating Activities in USD history and change rate from 30 Jun 2023 to 30 Sep 2025.
  • Silexion Therapeutics Corp Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 30 Sep 2025 was $0.
  • Silexion Therapeutics Corp Interest Paid, Excluding Capitalized Interest, Operating Activities for the twelve months ending 30 Sep 2025 was $40,000.
  • Silexion Therapeutics Corp annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $27,000.
Source SEC data
View on sec.gov
Interest Paid, Excluding Capitalized Interest, Operating Activities, Trailing 12 Months (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Change (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)

Silexion Therapeutics Corp Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $40,000 $0 $0 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $40,000 $0 $0 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $40,000 $13,000 +$13,000 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $27,000 $27,000 01 Oct 2024 31 Dec 2024 8-K 20 Aug 2025
Q3 2024 $0 -$42,000 -100% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $0 -$39,000 -100% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $0 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q3 2023 $42,000 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $39,000 01 Apr 2023 30 Jun 2023 10-Q 29 Aug 2024 2024 Q2

Silexion Therapeutics Corp Annual Interest Paid, Excluding Capitalized Interest, Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $27,000 +$27,000 01 Jan 2024 31 Dec 2024 8-K 20 Aug 2025
2023 $0 01 Jan 2023 31 Dec 2023 8-K 20 Aug 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.